Efficacy of antidepressants as analgesics: A review

Journal of Clinical Pharmacology

Volumn 52, Issue 1, 2012, Pages 6-17

  Dharmshaktu, Pinky ^a   Tayal, Vandana ^a   Kalra, Bhupinder Singh ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

antidepressants; back pain; fibromyalgia; headache; neuropathic pain

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOSULEPIN; DOXEPIN; DULOXETINE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MIANSERIN; MILNACIPRAN; MIRTAZAPINE; MORPHINE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PLACEBO; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ABSENCE OF SIDE EFFECTS; AGITATION; ANALGESIA; ANKYLOSING SPONDYLITIS; ANOREXIA; ANTIDEPRESSANT ACTIVITY; ANTINOCICEPTION; BLURRED VISION; BRIEF PAIN INVENTORY; COMA; CONFUSION; CONSTIPATION; DIABETIC NEUROPATHY; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPIGASTRIC DISCOMFORT; FATIGUE; FIBROMYALGIA; HALLUCINATION; HEADACHE; HEART PALPITATION; HOT FLUSH; HUMAN; HYPERHIDROSIS; HYPERTENSION; HYPERTHERMIA; HYPERTRANSAMINASEMIA; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INSOMNIA; LIBIDO DISORDER; LIVER TOXICITY; LOW BACK PAIN; MEMORY DISORDER; MIGRAINE; MYOCLONUS; NAUSEA; NAUSEA AND VOMITING; NEUROPATHIC PAIN; NEUROPATHY; ORGASM DISORDER; PAIN THRESHOLD; POLYNEUROPATHY; POSTHERPETIC NEURALGIA; PROPHYLAXIS; REVIEW; RHEUMATOID ARTHRITIS; SEROTONIN SYNDROME; SIDE EFFECT; SIGNAL TRANSDUCTION; SOMNOLENCE; SWEATING; TACHYCARDIA; TREATMENT DURATION; TREATMENT RESPONSE; TREMOR; URINE RETENTION; VOMITING; WEAKNESS; WEIGHT GAIN; XEROSTOMIA;

ANALGESICS; ANIMALS; ANTIDEPRESSIVE AGENTS; HUMANS; PAIN; SEROTONIN UPTAKE INHIBITORS;

EID: 84855437609     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270010394852     Document Type: Review

References (132)

1. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. 2 nd ed.Seattle, WA: IASP Press; 1994. Merskey H Bogduk N, ed. Seattle, WA: IASP Press ; 1994 :
2. Bouhassira D. Definition and classification of neuropathic pain [in French]. Presse Med. 2008 ; 37: 311-314
3. Woolf CJ, Decosterd I. Implications of recent advances in the understanding of pain pathophysiology for the assessment of pain in patients. Pain. 1999 ; (Suppl 6). S141 - S147
4. Woolf CJ. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med. 2004 ; 140: 441-451 (Pubitemid 38327332)
5. Tsang A, Von Korff M, Lee S, et al. Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. J Pain. 2008 ; 9: 883-891
6. Tunks ER, Crook J, Weir R. Epidemiology of chronic pain with psychological comorbidity: prevalence, risk, course, and prognosis. Can J Psychiatry. 2008 ; 53: 224-235
7. Mc Williams LA, Cox BJ, Enns MW. Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain. 2003 ; 106: 127-133 (Pubitemid 37329622)
8. Mc Williams LA, Goodwin RD, Cox BJ. Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain. 2004 ; 111: 77-83 (Pubitemid 39141009)
9. Von Korff M, Crane P, Lane M, et al. Chronic spinal pain and physical-mental comorbidity in the United States: results from the national comorbidity survey replication. Pain. 2005 ; 113: 331-339 (Pubitemid 40127515)
10. Kirmayer LJ, Robbins JM, Dworkind M, et al. Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry. 1993 ; 150: 734-741 (Pubitemid 23137678)
11. Hudson JL, Hudson MS, Pliner LF, et al. Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry. 1985 ; 142: 441-446 (Pubitemid 15108206)
12. Cummins TR, Sheets PL, Waxman SG. The roles of sodium channels in nociceptive: implications for mechanisms of pain. Pain. 2007 ; 131: 243-257 (Pubitemid 47374344)
13. Berta T, Poirot O, Pertin M, et al. Transcriptional and functional profiles of voltage-gated Na(+) channels in injured and non-injured DRG neurons in the SNI model of neuropathic pain. Mol Cell Neurosci. 2008 ; 37: 196-208 (Pubitemid 351173844)
14. Pertin M, Ji RR, Berta T, et al. Upregulation of the voltage-gated sodium channel beta 2 subunit in neuropathic pain models: characterization of expression in injured and non-injured primary sensory neurons. J Neurosci. 2005 ; 25: 10970-10980 (Pubitemid 41692627)
15. Lai J, Porreca F, Hunter JC, Gold MS. Voltage gated sodium channels and hyperalgesia. Annu Rev Pharmacol Toxicol. 2004 ; 44: 371-397 (Pubitemid 38263846)
16. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain. 1993 ; 52: 259-285 (Pubitemid 23080546)
17. Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicentre trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004 ; 50: 2974-2984 (Pubitemid 39209537)
18. Crofford LJ. Pharmaceutical treatment options for fibromyalgia. Curr Rheumatol Rep. 2004 ; 6: 274-280
19. Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature. 1983 ; 306: 686-688 (Pubitemid 14201852)
20. Cardenas DD, Warms CA, Turner JA, et al. Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial. Pain. 2002 ; 96: 365-373 (Pubitemid 34327885)
21. Sawnyok J, Esser MJ, Reid AR. Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci. 2001 ; 26: 21-29 (Pubitemid 32185176)
22. Gray AM, Pache DM, Sewell RD. Do alpha2-adrenoceptors play a role in the antinociceptive mechanism of action of antidepressant compounds?. Eur J Pharmacol. 1999 ; 378: 161-168 (Pubitemid 29356012)
23. Eschalier A, Montastruc JL, Devoize JL, Rigal F, Gaillard-Plaza G, Pechadre JC. Influence of naloxone and methysergide on the analgesic effect of clomipramine in rats. Eur J Pharmacol. 1981 ; 74: 1-7
24. Yokogawa F, Kiuchi Y, Ishikawa Y, et al. An investigation of monoamine receptors involved in antinociceptive effects of antidepressants. Anesth Analg. 2002 ; 95: 163-168 (Pubitemid 34705572)
25. Mico JA, Gibert-Rahola J, Casas J, Rojas O, Serrano MI, Serrano JS. Implication of b1- and b2-adrenergic receptors in the antinociceptive effect of tricyclic antidepressants. Eur Neuropsychopharmacol. 1997 ; 7: 139-145 (Pubitemid 27240347)
26. Cai Z, McCaslin PP. Amitriptyline, desipramine, cyproheptadine and carbamazepine, in concentrations used therapeutically, reduce kainite- and N-methyl-D-aspartate-induced intracellular Ca2+ levels in neuronal culture. Eur J Pharmacol. 1992 ; 219: 53-57
27. Skolnick P, Layer RT, Popik P, Nowak G, Paul IA, Trullas R. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry. 1996 ; 29: 23-26 (Pubitemid 26072654)
28. Ogata N, Yoshii M, Narahashi T. Psychotropic drugs block voltage-gated ion channels in neuroblastoma cells. Brain Res. 1989 ; 476: 140-144 (Pubitemid 19006374)
29. Sudoh Y, Cahoon EE, Gerner P, et al. Tricyclic antidepressants as long-acting local anesthetics. Pain. 2003 ; 103: 49-55 (Pubitemid 36579084)
30. Antkiewicz-Michaluk L, Romanska I, Michaluk J, Vetulani J. Role of calcium channels in effects of antidepressant drugs on responsiveness to pain. Psychopharmacology (Berl). 1991 ; 105: 269-274
31. Galeotti N, Ghelardini C, Bartolini A. Involvement of potassium channels in amitriptyline and clomipramine analgesia. Neuropharmacology. 2001 ; 40: 75-84 (Pubitemid 33779802)
32. Sawynok J, Reid AR, Liu XJ, Parkinson FE. Amitriptyline enhances extracellular tissue levels of adenosine in the rat hindpaw and inhibits adenosine uptake. Eur J Pharmacol. 2005 ; 518: 116-122 (Pubitemid 41133634)
33. McCarson KE, Duric V, Reisman SA, Winter M, Enna SJ. GABAB receptor function and subunit expression in the rat spinal cord as indicators of stress and the antinociceptive response to antidepressants. Brain Res. 2006 ; 1068: 109-117 (Pubitemid 43139269)
34. Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med. 1995 ; 332: 1685-1690
35. Gray AM, Spencer PS, Sewell RD. The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds. Br J Pharmacol. 1998 ; 124: 669-674 (Pubitemid 28276803)
36. Yaron I, Shirazi I, Judovich R, Levartovsky D, Caspi D, Yaron M. Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum. 1999 ; 42: 2561-2568 (Pubitemid 30327172)
37. Ignatowski TA, Sud R, Reynolds JL, Knight PR, Spengler RN. The dissipation of neuropathic pain paradoxically involves the presence of tumor necrosis factor-a (TNF). Neuropharmacology. 2005 ; 48: 448-460 (Pubitemid 40250008)
38. Verdu B, Decosterd I, Buclin T, et al. Antidepressants for the treatment of chronic pain. Drugs.. 2008 ; 68: (18):2611-32
39. Perrot S, Javier RM, Marty M, Le Jeunne C, Laroche F. Is there any evidence to support the use of anti-depressants in painful rheumatological conditions? Systematic review of pharmacological and clinical studies. Rheumatology (Oxford). 2008 ; 47: 1117-1123 (Pubitemid 352038213)
40. Kieburtz K, Simpson D, Yiannoutsos C, et al. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team. Neurology. 1998 ; 51: 1682-1688 (Pubitemid 28565253)
41. Mercadante S, Arcuri E, Tirelli W, et al. Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study. Tumor. 2002 ; 88: 239-242 (Pubitemid 34875452)
42. Robinson LR, Czerniecki JM, Ehde DM, et al. Trial of amitriptyline for relief of pain in amputees: results of a randomized controlled study. Arch Phys Med Rehabil. 2004 ; 85: 1-6 (Pubitemid 38049583)
43. Max MB, Culnane M, Schafer SC, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology. 1987 ; 37: 589-596 (Pubitemid 17057933)
44. Max MB. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain. 1991 ; 45: 3-9
45. Saarto T, Wiffen PJ. Cochrane Database Syst Rev. 2007 ; 4 :
46. Salerno SM, Browning R, Jackson JL. The effect of antidepressant treatment on chronic back pain: a meta-analysis. Arch Intern Med. 2002 ; 162: 19-24 (Pubitemid 34073395)
47. Onghena P, Van Houdenhove B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain. 1992 ; 49: 205-202
48. Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia. A randomized, placebo-controlled trial. Neurology. 2002 ; 59: 1015-1021
49. Sindrup SH, Bach FW, Madsen C, Gram LF, Jensen TS. Venlafaxine versus imipramine in painful polyneuropathy: a randomized controlled trial. Neurology. 2003 ; 60: 1284-1289 (Pubitemid 36460983)
50. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med. 1992 ; 326: 1250-1256
51. Rowbotham MC, Goli V, Kunz NR, et al. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain. 2004 ; 110: 697-706 (Pubitemid 39036802)
52. Goldstein DJ, Lu Y, Detke MJ, et al. Duloxetine vs placebo in patients with painful diabetic neuropathy. Pain. 2005 ; 116: 109-118 (Pubitemid 40828506)
53. Wernicke JF, Pritchett YL, D'Souza DM, et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology. 2006 ; 67: 1411-1420 (Pubitemid 44632065)
54. Norregard J, Volkmann H, Danneskiold-Samsoe B. A randomized controlled study of citalopram in the treatment of fibromyalgia. Pain. 1995 ; 61: 445-449
55. Heymann RE, Helfenstein M, Feldman D. A double-blind, randomized, controlled study of amitriptyline, nortriptyline and placebo in patients with fibromyalgia. Clin Exp Rheumatol. 2001 ; 19: 697-702 (Pubitemid 34026834)
56. Arnold LM, Hess EV, Hudson JI, Welge JA, Berno SE, Keck PE. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med. 2002 ; 112: 191-197
57. Mease PJ, Clauw DJ, Gendreau RM, et al. The efficacy and safety of milnacipran for treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial. J Rheumatol. 2009 ; 36: 398-409
58. O'Malley PG, Balden E, Tomkins G, et al. Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Intern Med. 2000 ; 15: 659-666
59. Dickens C, Jayson M, Sutton C, Creed F. The relationship between pain and depression in a trial using paroxetine in sufferers of chronic low back pain. Psychosomatics. 2000 ; 41: 490-499
60. Katz J, Pennella-Vaughan J, Hetzel RD, et al. A randomized, placebo-controlled trial of bupropion sustained release in chronic low back pain. J Pain. 2005 ; 6: 656-661 (Pubitemid 41395057)
61. Staiger TO, Gaster B, Sullivan MD, et al. Systematic review of antidepressants in the treatment of chronic low back pain. Spine. 2003 ; 28: 2540-2545 (Pubitemid 37448972)
62. Jenkins DG, Ebbutt AF, Evans CD. Tofranil in the treatment of low back pain. J Int Med Res. 1976 ; 4: 28-40
63. Ash G, Dickens CM, Creed FH, Jayson MI, Tomenson B. The effects of dothiepin on subjects with rheumatoid arthritis and depression. Rheumatology. 1999 ; 38: 959-967 (Pubitemid 29505077)
64. Koh WH, Pande I, Samuels A, Jones SD, Calin A. Low-dose amitriptyline in ankylosing spondylitis: a short-term, double-blind, placebo-controlled study. J Rheumatol. 1997 ; 4: 2158-2161
65. Bryson HM, Wilde MI. Amitriptyline: a review of its pharmacological properties and the therapeutic use in chronic pain states. Drugs Aging. 1996 ; 8: 459-476 (Pubitemid 26163141)
66. Galer BS. Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology. 1995 ; 45 (Suppl 9). 17-25
67. Attal N, Cruccua G, Haanpaa M, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006 ; 13: 1153-1169 (Pubitemid 44581463)
68. Leijon G, Boivie J. Central post-stroke pain: a controlled trial of amitriptyline and carbamazepine. Pain. 1989 ; 36: 27-36 (Pubitemid 19024963)
69. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005 ; 118: 289-305 (Pubitemid 41752987)
70. Goldenberg DL, Felson DT, Dinerman H. A randomised, controlled trial of amitriptyline and naproxene in the treatment of patients with fibromyalgia. Arthritis Rheum. 1986 ; 29: 1371-1377 (Pubitemid 17214038)
71. Carette S, McCain GA, Bell DA, Fam AG. Evaluation of amitriptyline in primary fibrositis. A double-blinded, placebo-controlled study. Arthritis Rheum. 1986 ; 29: 655-659 (Pubitemid 16056834)
72. Bibolotti E, Borghi C, Pasculli E, et al. The management of fibrositis. A double-blind comparison of maprotiline (Ludiomil) clorimipramine and placebo. Clin Trials J. 1986 ; 23: 269-280 (Pubitemid 17229187)
73. Caruso I, Sarzi Puttini PC, Boccassini L, et al. Double-blind study of dothiepin versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res. 1987 ; 15: 154-159 (Pubitemid 17096794)
74. Bennett RM, Gatter RA, Campbell SM, Andrews RP, Clark SR, Scarola JA. A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study. Arthritis Rheum. 1988 ; 31: 1535-1542 (Pubitemid 19028420)
75. Hamaty D, Valentine JL, Howard R, Howard CW, Wakefield V, Patten MS. The plasma endorphin, prostaglandin and catecholamine profile of patients with fibrositis treated with cyclobenzaprine and placebo: a 5-month study. J Rheumatol. 1989 ; 19 (Suppl). 164-168 (Pubitemid 20015413)
76. Scudds RA, McCain GA, Rollman GB, Harth M. Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline. J Rheumatol. 1989 ; 19 (Suppl). 98-103 (Pubitemid 20015401)
77. Quimby LG, Gratwick GM, Whitney CD, Block SR. A randomized trial of cyclobenzaprine for the treatment of fibromyalgia. J Rheumatol. 1989 ; 19 (Suppl). 140-143 (Pubitemid 20015408)
78. Reynolds WJ, Moldofsky H, Saskin P, Lue FA. The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia. J Rheumatol. 1991 ; 18: 452-454
79. Fossaluzza V, De Vita S. Combined therapy with cyclobenzaprine and ibuprofen in primary fibromyalgia syndrome. Int J Clin Pharm Res. 1992 ; XII: 99-102
80. Carette S, Bell MJ, Reynolds WJ, et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. Arthritis Rheum. 1994 ; 37: 32-40
81. Cantini F, Bellandi F, Niccoli L, Di Munno O. Fluoxetina associata a ciclobenzaprina nel trattamento della fibromialgia. Minerva Med. 1994 ; 85: 97-100 (Pubitemid 24180133)
82. Goldenberg D, Mayskiy M, Mossey C, Ruthaser R, Schmid C. A randomized, doubleblind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum. 1996 ; 39: 1852-1859 (Pubitemid 26378576)
83. Ginsberg F, Mancaux A, Joos E, Vanhove P, Famaey JP. A randomized placebo controlled trial of sustained-release amitriptyline in primary fibromyalgia. J Musculoskel Pain. 1996 ; 4: 37-47
84. Hannonen P, Malminiemi K, Yli-Kerttula U, Isomeri R, Roponen P. A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder. Br J Rheumatol. 1998 ; 37: 1279-1286
85. Arnold LM, Keck PE, Welge JA. Antidepressant treatment of fibromyalgia: a meta-analysis and review. Psychosomatics. 2000 ; 41: 104-113 (Pubitemid 30159888)
86. Chou R, Huffman LH. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians Clinical practice guideline. Ann Intern Med. 2007 ; 147: 505-514 (Pubitemid 351664521)
87. Schnitzer TJ, Ferraro A, Hunsche E, Kong SX. A comprehensive review of clinical trials on the efficacy and safety of drugs for the treatment of low back pain. Pain Symptom Manage. 2004 ; 28: 72-95 (Pubitemid 38829674)
88. Stein D, Peri T, Edelstein E, Elizur A, Floman Y. The efficacy of amitriptyline and acetaminophen in the management of acute low back pain. Psychosomatics. 1996 ; 36: 63-70 (Pubitemid 26021822)
89. Atkinson JH, Slater MA, Williams RA, et al. A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain. 1998 ; 76: 287-296 (Pubitemid 28342738)
90. Atkinson JH, Slater MA, Wahlgren DR, et al. Effects of nor-adrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain. 1999 ; 83: 137-145 (Pubitemid 29479271)
91. Lin EH, Katon W, Von Korff M, et al. Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial. J Am Med Assoc. 2003 ; 290: 2428-2429
92. McQuay HJ, Carroll D, Glynn CJ. Dose-response for analgesic effect of amitriptyline in chronic pain. Anaesthesia. 1993 ; 48: 281-285 (Pubitemid 23135505)
93. Wheatley D. Antidepressants in elderly arthritics. Practitioner. 1986 ; 230: 477-481 (Pubitemid 16109817)
94. Tomkins GE, Jackson JL, O'Malley PG, et al. Treatment of chronic headache with antidepressants: a meta-analysis. Am J Med. 2001 ; 111: 54-63 (Pubitemid 32635262)
95. Silberstein SD. Preventive treatment of migraine. Trends Pharmacol Sci. 2006 ; 27: 410-415 (Pubitemid 44051566)
96. Sarchielli P, Mancini ML, Calabresi P. Practical considerations for the treatment of elderly patients with migraine. Drugs Aging. 2006 ; 23: 461-489 (Pubitemid 44162302)
97. Anderberg UA, Marteinsdottir I, von Knorring L. Citalopram in patients with fibromyalgia-a randomised, double-blind, placebo-controlled study. Eur J Pain. 2000 ; 4: 27-35 (Pubitemid 30230793)
98. Geller SA. Treatment of fibrositis with fluoxetine hydrochloride (Prozac). Am J Med. 1989 ; 87: 594-595 (Pubitemid 19274770)
99. Cortet B, Houvenagel E, Forzy G, Vincent G, Delcambre B. Evaluation of the effectiveness of serotonin (fluoxetine hydrochloride) treatment. Open study in fibromyalgia. Rev Rhum Mal Osteoartic. 1992 ; 59: 497-500
100. Wolfe F, Cathey MA, Hawley DJ. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol. 1994 ; 23: 255-259 (Pubitemid 24334031)
101. Ataoglu S, Ataoglu A, Erdoan F, Sarac J. Comparison of paroxetine, amitriptyline in the treatment of fibromyalgia. Turk J Med Sci. 1997 ; 27: 535-539 (Pubitemid 28133849)
102. Patkar AA, Masand PS, Krulewicz S, et al. A randomized, controlled, trial of controlled-release paroxetine in fibromyalgia. Am J Med. 2007 ; 120: 448-454 (Pubitemid 46656247)
103. Sindrup SH, Gram LF, Brosen K, et al. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain. 1990 ; 42: 135-144 (Pubitemid 20258898)
104. Ciaramella A, Grosso S, Poli P. Fluoxetine versus fluvoxamine for treatment of chronic pain [in Italian]. Minerva Anestesiol. 2000 ; 66: 55-61
105. Maina G, Vitalucci A, Gandolfo S, et al. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study. J Clin Psychiatry. 2002 ; 63: 38-43 (Pubitemid 34113485)
106. Sindrup SH, Bjerre U, Dejgaard A, et al. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther. 1992 ; 52: 547-552
107. MojaPLCusiCSterziRR. Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev. 2005;3:CD002919.
108. Lithner F. Venlafaxine in treatment of severe painful peripheral diabetic neuropathy. Diabetes Care. 2000 ; 23: 1710-1711
109. Sumpton JE, Moulin DE. Treatment of neuropathic pain with venlafaxine. Ann Pharmacother. 2001 ; 35: 557-559 (Pubitemid 32428129)
110. Sayar K, Aksu G, Ak I, Tosun M. Venlafaxine treatment of fibromyalgia. Ann Pharmacother. 2003 ; 37: 1561-1565 (Pubitemid 37315091)
111. Dwight MM, Arnold LD, O'Brien H, Metzger R, Morris-Park E, Keck PE. An open trial of venlafaxine treatment of fibromyalgia. Psychosomatics. 1998 ; 39: 14-17 (Pubitemid 28152592)
112. Arnold LM, Rosen A, Pritchett YL, et al. A randomised, double-blind, placebo controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005 ; 119: 5-15 (Pubitemid 41752960)
113. Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther. 2008 ; 30: 1988-2004
114. Ozyalcin SN, Talu GK, Kiziltan E, et al. The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache. 2005 ; 45: 144-152 (Pubitemid 40315784)
115. Bulut S, Berilgen MS, Barar A, et al. Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study. Clin Neurol Neurosurg. 2004 ; 107: 44-48 (Pubitemid 39556678)
116. Pakulska W, Czarnecka E. Influence of mianserin on the antinociceptive effect of morphine, metamizol and indomethacin in mice. Pharmacol Res. 2002 ; 46: 415-423 (Pubitemid 35352204)
117. Sindrup SH, Tuxen C, Gram LF, et al. Lack of effect of mianserin on the symptoms of diabetic neuropathy. Eur J Clin Pharmacol. 1992 ; 43: 251-255
118. Zhu J, Wei X, Feng X, Song J, Hu Y, Xu J. Repeated administration of mirtazapine inhibits development of hyperalgesia/allodynia and activation of NF-kappaB in a rat model of neuropathic pain. Neurosci Lett. 2008 ; 433: 33-37
119. Freynhagen R, Muth-Selbach U, Lipfert P, et al. The effect of mirtazapine in patients with chronic pain and concomitant depression. Curr Med Res Opin. 2006 ; 22: 257-264 (Pubitemid 44296749)
120. Pick CG, Paul D, Eison MS, Pasternak GW. Potentiation of opioids analgesia by the antidepressant nefazodone. Eur J Pharmacol. 1992 ; 211: 375-381
121. Baldessarini RJ The Pharmacological Basis of Therapeutics. Goodman GA Rall TTW Nies AS Taylor P, ed. New York: Pergamon Press ; 1990: 383-435.
122. Glassman AH, Bigger JT. Cardiovascular effects of therapeutic doses of tricyclic antidepressants. Arch Gen Psychiatry. 1981 ; 36: 815-819
123. Eschalier A, Ardid D, Dubray C Novel Aspects of Pain Management: Opioids and Beyond. Sawynok J Cowan A, ed. New York: Wiley-Liss ; 1999: 303-319.
124. McQuay HJ, Tramèr M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain. 1996 ; 68: 217-227 (Pubitemid 27025878)
125. Rintala DH, Holmes SA, Courtade D, et al. Comparison of the effectiveness of amitriptyline and gabapentin in chronic neuropathic pain in persons with spinal cord injury. Arch Phys Med Rehabil. 2007 ; 88: 1547-1560 (Pubitemid 350151394)
126. Pancrazio JJ, Kamatchi GL, Roscoe AK, Lynch C. Inhibition of neuronal Na+ channels by antidepressant drugs. J Pharmacol Exp Ther. 1998 ; 284: 208-214 (Pubitemid 28109548)
127. Harrigan RA, Brady WJ. ECG abnormalities in tricyclic antidepressant ingestion. Am J Emerg Med. 1999 ; 17: 387-393 (Pubitemid 29369826)
128. Liu BA, Mittmann N, Knowles SR, et al. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports. Can Med Assoc J. 1996 ; 155: 519-527 (Pubitemid 26316956)
129. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005 ; 352: 1112-1120
130. Dworkin RH, O'Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010 ; 85: S3 - S14
131. Rosenzweig TM, Thomas TM. An update on fibromyalgia syndrome: the multimodal therapeutic approach. Am J Lifestyle Med. 2009 ; 3: 226-237
132. An updated report by the American Society of Anesthesiologists Task Force on Chronic Pain Management and the American Society of Regional Anesthesia and Pain Medicine. Anesthesiology. 2010 ; 112: 810-833